Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.
Guillermo Garcia-Manero,Ghulam J Mufti,Pierre Fenaux,Rena Buckstein,Valeria Santini,María Díez-Campelo,Carlo Finelli,Osman Ilhan,Mikkael A Sekeres,Amer M Zeidan,Rodrigo Ito,Jennie Zhang,Anita Rampersad,Daniel Sinsimer,Jay T Backstrom,Uwe Platzbecker,Rami S Komrokji Blood(2022)
AI 理解论文
溯源树
样例